← Eichor
Condition: Immune Related Adverse Events Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Related Adverse Events

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibi
Phase N/A · 6 location(s) · Shantou University Medical College · NCT07357636Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
NA · 2 location(s) · Radboud University Medical Center · NCT07680556Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110The CARDIOPROTECT Trial
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07654426ATROPOS: Survival Analysis of ICI-associated Myocarditis
Phase N/A · 1 location(s) · Groupe Hospitalier Pitie-Salpetriere · NCT07633587The Effect of Serum Ferritin in irAE
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06702566Montreal Immune-Related Adverse Events (MIRAE) Study
Phase N/A · 1 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT05139706Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
Phase N/A · 1 location(s) · West China Second University Hospital · NCT06132984Food Intervention to Reduce Immunotherapy ToXicity
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT05832606Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT07453342Analysis of the Role of IgE Proteoforms in Health and Disease
Phase N/A · 1 location(s) · KU Leuven · NCT07328178Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06461780SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Phase 2 · 3 location(s) · Queensland Centre for Gynaecological Cancer · NCT06278857Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Diseas
Phase N/A · 1 location(s) · Hospital Universitario Araba · NCT07249060Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Phase N/A · 11 location(s) · University Hospital, Lille · NCT04330118Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Phase 2 · 2 location(s) · Sun Yat-sen University · NCT07644897Early Assessment of Cardiac Function After Treatment With CAR-T Cells
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06350994Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic E
EARLY_Phase 1 · 1 location(s) · Peng Zhang · NCT06119490Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
Phase N/A · 1 location(s) · Xijing Hospital · NCT06613165A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoi
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06647134Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older
Phase N/A · 2 location(s) · University of Zurich · NCT07309497Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Phase N/A · 2 location(s) · University of Geneva, Switzerland · NCT05512169Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids
Phase N/A · 2 location(s) · University Hospital, Basel, Switzerland · NCT07167251LYell SYndrome MEsenchymal Stromal Cells Treatment
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04711200Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · 625 location(s) · Alliance for Clinical Trials in Oncology · NCT04242095Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 · 1 location(s) · Brian Henick, MD · NCT06673329A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Epi
Phase N/A · 3 location(s) · Oxford Biodynamics Inc. · NCT06635954GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT04654923Checkpoint Inhibitor-induced Liver Injury
Phase N/A · 1 location(s) · University of Nottingham · NCT04476563
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.